Sparton to manufacture PathoGenetix RESOLUTION microbial genotyping system Sparton has been chosen by PathoGenetix as the design and manufacturing partner for their RESOLUTION microbial genotyping system. PathoGenetix is a developer of an automated system for rapid bacterial strain typing. Under the terms of the agreement, Sparton will conduct design for manufacture and pilot production of a limited number of pre-commercial instruments for the RESOLUTION System, which is slated for commercial availability in late 2014. Pre-commercial units of the RESOLUTION System are currently undergoing testing and evaluation by government and food industry partners.
Sparton upgraded to Outperform from Market Perform at Barrington Barrington upgraded Sparton to Outperform with a $31 price target saying the company's new five]year plan should drive share appreciation.